Placebo (adjuvant only)

BIOLOGICAL2 trials

Sponsors

PepTcell Limited, Nuravax, Inc.

Conditions

Alzheimer DiseaseAlzheimer Disease (AD)InfluenzaPreclinical Alzheimer's Disease

Phase 1

Influenza Vaccine Challenge Study in Healthy Subjects

CompletedNCT01226758

PepTcell LimitedInfluenza

Start: 2010-06-30End: 2010-12-31Updated: 2012-11-02

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Not yet recruitingNCT07142278

Nuravax, Inc.Alzheimer Disease, Alzheimer Disease (AD), Preclinical Alzheimer's Disease

Start: 2026-10-20End: 2027-07-31Target: 24Updated: 2026-08-24

Related Papers

Meta-Analysis and Potential Role of Preexisting Heterosubtypic Cellular Immunity Based on Variations in Disease Severity Outcomes for Influenza Live Viral Challenges in Humans.

2015-06-1711 citations

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans

Clinical and Vaccine Immunology2015-05-2060 citations